0001478242-20-000016.txt : 20200220 0001478242-20-000016.hdr.sgml : 20200220 20200220170512 ACCESSION NUMBER: 0001478242-20-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200218 FILED AS OF DATE: 20200220 DATE AS OF CHANGE: 20200220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAUB W RICHARD CENTRAL INDEX KEY: 0001181162 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 20636178 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 271341991 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-02-18 0001478242 IQVIA HOLDINGS INC. IQV 0001181162 STAUB W RICHARD C/O IQVIA HOLDINGS INC. 4820 EMPEROR BLVD. DURHAM NC 27703 0 1 0 0 See Remarks Common Stock 2020-02-18 4 M 0 18224 78.21 A 35953 D Common Stock 2020-02-18 4 S 0 14550 163.77 D 21403 D Common Stock 2020-02-18 4 D 0 8674 165.42 D 12729 D Stock Appreciation Right 78.21 2020-02-18 4 M 0 18224 0 D 2020-02-02 2027-02-02 Common Stock 18224 0 D The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $162.84 to $164.91 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. President, Research & Development Solutions /s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub 2020-02-20